Ontology highlight
ABSTRACT:
SUBMITTER: Gampenrieder SP
PROVIDER: S-EPMC4322685 | biostudies-literature | 2014 Oct
REPOSITORIES: biostudies-literature
Gampenrieder Simon P SP Rinnerthaler Gabriel G Greil Richard R
Breast care (Basel, Switzerland) 20141001 5
Bone-targeted therapies like bisphosphonates (zoledronic acid or pamidronate) or denosumab are recommended in all patients with metastatic breast cancer and bone metastases, whether they are symptomatic or not. The choice between these 2 different agents, however, remains open. In this review, we critically discuss the emerging evidence for direct anti-tumor activity of bone-targeting agents, the utility of bone turnover markers for treatment decision and efficacy prediction, as well as the safe ...[more]